666 related articles for article (PubMed ID: 22125963)
1. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
[TBL] [Abstract][Full Text] [Related]
2. Studying the penetration of fatty acids into human skin by ex vivo TOF-SIMS imaging.
Kezutyte T; Desbenoit N; Brunelle A; Briedis V
Biointerphases; 2013 Dec; 8(1):3. PubMed ID: 24706116
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
4. Assay of tolnaftate in human skin samples after in vitro penetration studies using high performance liquid chromatography.
Kezutyte T; Kornysova O; Maruska A; Briedis V
Acta Pol Pharm; 2010; 67(4):327-34. PubMed ID: 20635527
[TBL] [Abstract][Full Text] [Related]
5. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems.
AbouSamra MM; Salama AH
J Liposome Res; 2017 Dec; 27(4):324-334. PubMed ID: 27666873
[TBL] [Abstract][Full Text] [Related]
7. Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornum by in vivo confocal Raman spectroscopy.
Mélot M; Pudney PD; Williamson AM; Caspers PJ; Van Der Pol A; Puppels GJ
J Control Release; 2009 Aug; 138(1):32-9. PubMed ID: 19401210
[TBL] [Abstract][Full Text] [Related]
8. Effects of various vehicles on the penetration of flufenamic acid into human skin.
Wagner H; Kostka KH; Adelhardt W; Schaefer UF
Eur J Pharm Biopharm; 2004 Jul; 58(1):121-9. PubMed ID: 15207545
[TBL] [Abstract][Full Text] [Related]
9. Polyoxyethylene fatty acid esters as potential promotors of transdermal absorption for morphine hydrochloride and sulphate.
Samczewska G; Piechota-Urbańska M; Kołodziejska J
Polim Med; 2006; 36(2):17-32. PubMed ID: 17022153
[TBL] [Abstract][Full Text] [Related]
10. Effects of fatty acids and iontophoresis on the delivery of midodrine hydrochloride and the structure of human skin.
Wang Y; Fan Q; Song Y; Michniak B
Pharm Res; 2003 Oct; 20(10):1612-8. PubMed ID: 14620516
[TBL] [Abstract][Full Text] [Related]
11. Effect of various marine lipids on transdermal drug delivery--in vitro evaluation.
Loftsson T; Gunnarsdóttir T; Magnúsdóttir LM; Frioriksdóttir H; Guomundsdóttir TK; Olafsson JH; Haraldsson GG; Guomundsson G; Hjaltason B
Boll Chim Farm; 1997 Nov; 136(10):640-5. PubMed ID: 9528172
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes.
Chisty MN; Bellantone RA; Taft DR; Plakogiannis FM
Drug Dev Ind Pharm; 2002 Nov; 28(10):1221-9. PubMed ID: 12476868
[TBL] [Abstract][Full Text] [Related]
13. Influence of formulation on the in vitro transdermal penetration of flutrimazole.
Ramis J; Conte L; Segado X; Forn J; Lauroba J; Calpena A; Escribano E; Domenech J
Arzneimittelforschung; 1997 Oct; 47(10):1139-44. PubMed ID: 9368709
[TBL] [Abstract][Full Text] [Related]
14. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of acyclovir and ketoconazole.
Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
[TBL] [Abstract][Full Text] [Related]
16. [In vitro comparison of transdermal characteristics of xiaoyu ointment and xiaoyu plaster].
Zhu C; Peng L; Chen B; He Q; Wen Q
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1599-602. PubMed ID: 22007541
[TBL] [Abstract][Full Text] [Related]
17. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.
Yener G; Gönüllü U; Uner M; Değim T; Araman A
Pharmazie; 2003 May; 58(5):330-3. PubMed ID: 12779049
[TBL] [Abstract][Full Text] [Related]
18. Dermal targeting of tacrolimus using colloidal carrier systems.
Goebel AS; Neubert RH; Wohlrab J
Int J Pharm; 2011 Feb; 404(1-2):159-68. PubMed ID: 21094231
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of ubidecarenone transdermal delivery systems.
Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
